Cite

HARVARD Citation

    Daher, M. et al. (n.d.). An exploratory clinical trial of bortezomib in patients with lower risk myelodysplastic syndromes. American journal of hematology. 92 (7), pp. 674-682. [Online]. 
  
Back to record